Vision Capital Management’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $12.4M | Sell |
50,861
-5,703
| -10% | -$1.33M | 1.57% | 16 |
|
|
2025
Q4 | $11.7M | Sell |
56,564
-1,475
| -3% | -$292K | 1.41% | 15 |
|
|
2025
Q3 | $10.8M | Sell |
58,039
-127
| -0.2% | -$21.8K | 1.33% | 18 |
|
|
2025
Q2 | $8.88M | Buy |
58,166
+468
| +0.8% | +$71.9K | 1.17% | 22 |
|
|
2025
Q1 | $9.57M | Buy |
57,698
+2,412
| +4% | +$377K | 1.38% | 17 |
|
|
2024
Q4 | $8M | Sell |
55,286
-10,789
| -16% | -$1.67M | 1.17% | 22 |
|
|
2024
Q3 | $10.7M | Buy |
66,075
+7,577
| +13% | +$1.21M | 1.51% | 19 |
|
|
2024
Q2 | $8.55M | Sell |
58,498
-248
| -0.4% | -$36.9K | 1.27% | 24 |
|
|
2024
Q1 | $9.29M | Buy |
58,746
+7,781
| +15% | +$1.24M | 1.39% | 20 |
|
|
2023
Q4 | $7.99M | Buy |
50,965
+294
| +0.6% | +$45.1K | 1.25% | 26 |
|
|
2023
Q3 | $7.89M | Sell |
50,671
-1,735
| -3% | -$286K | 1.45% | 22 |
|
|
2023
Q2 | $8.67M | Sell |
52,406
-326
| -0.6% | -$52.6K | 1.48% | 20 |
|
|
2023
Q1 | $8.17M | Sell |
52,732
-1,110
| -2% | -$179K | 1.48% | 21 |
|
|
2022
Q4 | $9.51M | Buy |
53,842
+724
| +1% | +$125K | 1.82% | 17 |
|
|
2022
Q3 | $8.68M | Buy |
53,118
+26,624
| +100% | +$4.51M | 1.79% | 13 |
|
|
2022
Q2 | $4.7M | Sell |
26,494
-48
| -0.2% | -$8.55K | 0.89% | 35 |
|
|
2022
Q1 | $4.7M | Sell |
26,542
-3,148
| -11% | -$536K | 0.77% | 36 |
|
|
2021
Q4 | $5.08M | Hold |
29,690
| – | – | 0.76% | 37 |
|
|
2021
Q3 | $4.79M | Buy |
29,690
+296
| +1% | +$50.5K | 0.78% | 38 |
|
|
2021
Q2 | $4.84M | Buy |
29,394
+2,093
| +8% | +$347K | 0.8% | 37 |
|
|
2021
Q1 | $4.49M | Buy |
27,301
+436
| +2% | +$70.5K | 0.8% | 38 |
|
|
2020
Q4 | $4.23M | Buy |
26,865
+967
| +4% | +$143K | 0.79% | 36 |
|
|
2020
Q3 | $3.86M | Sell |
25,898
-42
| -0.2% | -$6.21K | 0.81% | 34 |
|
|
2020
Q2 | $3.65M | Sell |
25,940
-968
| -4% | -$141K | 0.84% | 34 |
|
|
2020
Q1 | $3.53M | Buy |
26,908
+1,913
| +8% | +$271K | 0.94% | 29 |
|
|
2019
Q4 | $3.65M | Buy |
24,995
+1,677
| +7% | +$227K | 0.85% | 36 |
|
|
2019
Q3 | $3.02M | Buy |
23,318
+3,480
| +18% | +$458K | 0.78% | 38 |
|
|
2019
Q2 | $2.76M | Sell |
19,838
-310
| -2% | -$42.9K | 0.73% | 42 |
|
|
2019
Q1 | $2.82M | Buy |
20,148
+305
| +2% | +$40.9K | 0.78% | 40 |
|
|
2018
Q4 | $2.56M | Buy |
19,843
+707
| +4% | +$98.6K | 0.81% | 42 |
|
|
2018
Q3 | $2.64M | Buy |
19,136
+120
| +0.6% | +$15.9K | 0.72% | 49 |
|
|
2018
Q2 | $2.31M | Buy |
19,016
+160
| +0.8% | +$20K | 0.67% | 49 |
|
|
2018
Q1 | $2.42M | Buy |
18,856
+759
| +4% | +$103K | 0.71% | 46 |
|
|
2017
Q4 | $2.53M | Buy |
18,097
+5
| +0% | +$696 | 0.74% | 42 |
|
|
2017
Q3 | $2.35M | Buy |
18,092
+25
| +0.1% | +$3.31K | 0.75% | 43 |
|
|
2017
Q2 | $2.39M | Buy |
18,067
+5,416
| +43% | +$691K | 0.82% | 41 |
|
|
2017
Q1 | $1.58M | Buy |
12,651
+6,083
| +93% | +$727K | 0.57% | 47 |
|
|
2016
Q4 | $757K | Sell |
6,568
-9,686
| -60% | -$1.12M | 0.3% | 56 |
|
|
2016
Q3 | $1.92M | Buy |
16,254
+6,873
| +73% | +$834K | 0.8% | 46 |
|
|
2016
Q2 | $1.14M | Buy |
+9,381
| New | +$1.07M | 0.48% | 52 |
|
Other funds holding JNJ
VCM
VPM
Vision Capital Management's JNJ Position: Q1 2026 in Review
Vision Capital Management reduced its Johnson & Johnson (JNJ) stake by 10% in Q1 2026, selling an estimated $1.33M and leaving 50,861 shares worth $12.4M. The position accounts for 1.57% of the portfolio, ranked #16.
Vision Capital Management first reported a position in JNJ in Q2 2016 and has held it in 40 quarters since. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- Vision Capital Management held 50,861 shares of Johnson & Johnson worth $12.4M as of Q1 2026.
- Vision Capital Management sold 5,703 Johnson & Johnson shares in Q1 2026, an estimated $1.33M.
- Johnson & Johnson made up 1.57% of Vision Capital Management's portfolio in Q1 2026, its #16 holding.
- Vision Capital Management first reported a position in Johnson & Johnson in Q2 2016 and has held it in 40 quarters since.
- 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on Vision Capital Management's 13F filing for Q1 2026, filed 24 Apr 2026.